Trial Profile
A single centre, open label study to compare the pharmacokinetic profiles between once-daily (Advagraf®) and twice-daily (Prograf®) formulation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 12 Nov 2016 New trial record